Bo Shen

Metabolically unhealthy obesity is a novel risk factor for cisplatin- associated nephrotoxicity in patients with bladder cancer: a retrospective cohort study

Abstract Purpose Cisplatin-associated nephrotoxicity limits chemotherapy in bladder cancer patients. Obesity defined by body mass index (BMI) has yielded conflicting findings regarding the prediction of nephrotoxicity, possibly due to metabolic heterogeneity within the obese popu...